VEuPathDB资源:一个免费在线数据探索,集成和分析的平台
Omar S Harb1, Mary Ann McDowell2, David S Roos3
1University of Pennsylvania, Philadelphia, PA, USA. oharb@sas.upenn.edu.
Methods in molecular biology (Clifton, N.J.)
|May 31, 2024
概括
VEuPathDB.org提供免费访问对真核病原体,载体和宿主反应的欧米数据. 该资源增强了研究传染病的研究人员的数据可访问性,可查找性和可重复使用性.
科学领域:
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
- 传染病研究 传染病研究
背景情况:
- 幼核原生动物和真菌病原体以及关节动物载体对全球健康构成重大挑战.
- 了解宿主对感染的反应对于开发有效的对策至关重要.
研究的目的:
- 为与真核病原体,载体和宿主-病原体相互作用相关的欧米数据提供一个集中,公开可访问的平台.
- 为研究界提高各种生物数据集的可访问性,可查找性和可重复使用性.
主要方法:
- 整合包括基因组,转录基因组,蛋白质基因组和表观基因组数据在内的全面的欧米数据集.
- 数据分析工作流程的标准化,以确保准确性和互操作性.
- 开发专门的搜索工具和用于in silico实验的图形策略系统.
主要成果:
- VEuPathDB.org 拥有来自相关生物体的精心策划的OMIC数据的庞大存储库.
- 标准化分析提供了补充数据,包括蛋白质域,途径信息和比较基因组学.
- 比较基因组工具有助于ortholog识别,细菌模式分析和合成可视化.
结论:
- VEuPathDB.org通过提供易于访问集成的OMIC数据和先进的分析工具来赋予研究人员权力.
- 该平台支持in silico实验,加速真核病原体和载体研究的发现.
- 促进数据的可重复使用性促进了合作研究,并促进了对宿主-病原体动态的理解.
相关概念视频
Statistical Software for Data Analysis and Clinical Trials
533
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
533
Biostatistics: Overview
238
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
238
ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
60
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
60


